Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review

• Published in: World journal of surgical oncology 2022-05, Vol.20 (1), p.146-146, Article 146
• Main Authors: Shafi, Ovais, Siddiqui, Ghazia
• Format: Article
• Language: English
• Subjects: Aging; AKT protein; ASCL1 protein; Beta2 protein; Brain cancer; c-Myc protein; Carcinogenesis; Causes of; Cell cycle; Cell differentiation; Cell fate; Circuits; Differentiation; Etiology; Fibroblast growth factor receptors; Gene expression; Genes; Genetic aspects; Glial cells; Glial fibrillary acidic protein; Glioblastoma; Glioblastoma cells; Glioblastoma multiforme; Glioblastoma origins; Gliogenesis; Health aspects; Inflammation; Mutation; Myc protein; Nestin; Neural stem cells; Neurogenesis; Neuronal-glial interactions; NF-κB protein; Older people; Origins; Phase transitions; Search engines; Signal transduction; Signaling; Stem cells; Transcription factors; Transforming growth factors; Tumors
• ISSN: 1477-7819; 1477-7819
• DOI: 10.1186/s12957-022-02602-5

Glioblastoma is one of the most aggressive tumors. The etiology and the factors determining its onset are not yet entirely known. This study investigates the origins of GBM, and for this purpose, it focuses primarily on developmental gliogenic processes. It also focuses on the impact of the related neurogenic developmental processes in glioblastoma oncogenesis. It also addresses why glial cells are at more risk of tumor development compared to neurons. Databases including PubMed, MEDLINE, and Google Scholar were searched for published articles without any date restrictions, involving glioblastoma, gliogenesis, neurogenesis, stemness, neural stem cells, gliogenic signaling and pathways, neurogenic signaling and pathways, and astrocytogenic genes. The origin of GBM is dependent on dysregulation in multiple genes and pathways that accumulatively converge the cells towards oncogenesis. There are multiple layers of steps in glioblastoma oncogenesis including the failure of cell fate-specific genes to keep the cells differentiated in their specific cell types such as p300, BMP, HOPX, and NRSF/REST. There are genes and signaling pathways that are involved in differentiation and also contribute to GBM such as FGFR3, JAK-STAT, and hey1. The genes that contribute to differentiation processes but also contribute to stemness in GBM include notch, Sox9, Sox4, c-myc gene overrides p300, and then GFAP, leading to upregulation of nestin, SHH, NF-κB, and others. GBM mutations pathologically impact the cell circuitry such as the interaction between Sox2 and JAK-STAT pathway, resulting in GBM development and progression. Glioblastoma originates when the gene expression of key gliogenic genes and signaling pathways become dysregulated. This study identifies key gliogenic genes having the ability to control oncogenesis in glioblastoma cells, including p300, BMP, PAX6, HOPX, NRSF/REST, LIF, and TGF beta. It also identifies key neurogenic genes having the ability to control oncogenesis including PAX6, neurogenins including Ngn1, NeuroD1, NeuroD4, Numb, NKX6-1 Ebf, Myt1, and ASCL1. This study also postulates how aging contributes to the onset of glioblastoma by dysregulating the gene expression of NF-κB, REST/NRSF, ERK, AKT, EGFR, and others.